Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532740 · ClinicalTrials.gov registry record
Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00532740 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 2,000 participants.
The verdict
NCT00532740 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how well radiolabeled glass beads work in treating patients with metastatic liver cancer that cannot be removed by surgery.
Interventions
- RADIATION Yttrium Y 90 glass microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2004-12 |
| Est. Completion | 2022-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00532740
The ClinicalTrials.gov registry entry for NCT00532740 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yttrium Y 90 glass microspheres is the first listed.
NCT00532740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00532740 about?
NCT00532740 is a clinical study titled "Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery". RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery. PURPOSE: This phase II trial is studying how we...
What is the current status of trial NCT00532740?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2004-12. Estimated completion is 2022-03-16.
What interventions are being tested in trial NCT00532740?
The interventions under investigation include: Yttrium Y 90 glass microspheres (RADIATION).
Who is sponsoring clinical trial NCT00532740?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.